Atlas Trials

Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)

Clinical trial NCT02050347 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02050347
Sponsor
Baylor College of Medicine
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Hodgkin's LymphomaB-Cell ALLB-Cell CLL
Start date
2014-04-01
Primary completion
2019-10-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.